466 related articles for article (PubMed ID: 35884382)
1. Cancer-Associated Fibroblasts in the Hypoxic Tumor Microenvironment.
Kim I; Choi S; Yoo S; Lee M; Kim IS
Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884382
[TBL] [Abstract][Full Text] [Related]
2. Metabolic reprogramming and crosstalk of cancer-related fibroblasts and immune cells in the tumor microenvironment.
Zhu Y; Li X; Wang L; Hong X; Yang J
Front Endocrinol (Lausanne); 2022; 13():988295. PubMed ID: 36046791
[TBL] [Abstract][Full Text] [Related]
3. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives.
Mao X; Xu J; Wang W; Liang C; Hua J; Liu J; Zhang B; Meng Q; Yu X; Shi S
Mol Cancer; 2021 Oct; 20(1):131. PubMed ID: 34635121
[TBL] [Abstract][Full Text] [Related]
4. Tumour response to hypoxia: understanding the hypoxic tumour microenvironment to improve treatment outcome in solid tumours.
Bigos KJ; Quiles CG; Lunj S; Smith DJ; Krause M; Troost EG; West CM; Hoskin P; Choudhury A
Front Oncol; 2024; 14():1331355. PubMed ID: 38352889
[TBL] [Abstract][Full Text] [Related]
5. Cancer-Associated Fibroblasts: Master Tumor Microenvironment Modifiers.
Wright K; Ly T; Kriet M; Czirok A; Thomas SM
Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980785
[TBL] [Abstract][Full Text] [Related]
6. Antifibrotic therapy to normalize the tumor microenvironment.
Hauge A; Rofstad EK
J Transl Med; 2020 May; 18(1):207. PubMed ID: 32434573
[TBL] [Abstract][Full Text] [Related]
7. HIF-1α/GPER signaling mediates the expression of VEGF induced by hypoxia in breast cancer associated fibroblasts (CAFs).
De Francesco EM; Lappano R; Santolla MF; Marsico S; Caruso A; Maggiolini M
Breast Cancer Res; 2013; 15(4):R64. PubMed ID: 23947803
[TBL] [Abstract][Full Text] [Related]
8. Natural Compounds Targeting Cancer-Associated Fibroblasts against Digestive System Tumor Progression: Therapeutic Insights.
Chiu KJ; Chiou HC; Huang CH; Lu PC; Kuo HR; Wang JW; Lin MH
Biomedicines; 2022 Mar; 10(3):. PubMed ID: 35327514
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic cancer and fibrosis: Targeting metabolic reprogramming and crosstalk of cancer-associated fibroblasts in the tumor microenvironment.
Li X; Zhou J; Wang X; Li C; Ma Z; Wan Q; Peng F
Front Immunol; 2023; 14():1152312. PubMed ID: 37033960
[TBL] [Abstract][Full Text] [Related]
10. Metabolic Reprogramming of Cancer Associated Fibroblasts: The Slavery of Stromal Fibroblasts.
Avagliano A; Granato G; Ruocco MR; Romano V; Belviso I; Carfora A; Montagnani S; Arcucci A
Biomed Res Int; 2018; 2018():6075403. PubMed ID: 29967776
[TBL] [Abstract][Full Text] [Related]
11. Cancer-associated fibroblasts: a multifaceted driver of breast cancer progression.
Luo H; Tu G; Liu Z; Liu M
Cancer Lett; 2015 Jun; 361(2):155-63. PubMed ID: 25700776
[TBL] [Abstract][Full Text] [Related]
12. Regulation of heterogeneous cancer-associated fibroblasts: the molecular pathology of activated signaling pathways.
Yoshida GJ
J Exp Clin Cancer Res; 2020 Jun; 39(1):112. PubMed ID: 32546182
[TBL] [Abstract][Full Text] [Related]
13. Cancer-associated fibroblasts secrete hypoxia-induced serglycin to promote head and neck squamous cell carcinoma tumor cell growth in vitro and in vivo by activating the Wnt/β-catenin pathway.
Xie J; Qi X; Wang Y; Yin X; Xu W; Han S; Cai Y; Han W
Cell Oncol (Dordr); 2021 Jun; 44(3):661-671. PubMed ID: 33651283
[TBL] [Abstract][Full Text] [Related]
14. Cancer associated-fibroblast-derived exosomes in cancer progression.
Li C; Teixeira AF; Zhu HJ; Ten Dijke P
Mol Cancer; 2021 Dec; 20(1):154. PubMed ID: 34852849
[TBL] [Abstract][Full Text] [Related]
15. Extracellular matrix (ECM) stiffness and degradation as cancer drivers.
Najafi M; Farhood B; Mortezaee K
J Cell Biochem; 2019 Mar; 120(3):2782-2790. PubMed ID: 30321449
[TBL] [Abstract][Full Text] [Related]
16. Cancer-associated fibroblasts and resistance to anticancer therapies: status, mechanisms, and countermeasures.
Feng B; Wu J; Shen B; Jiang F; Feng J
Cancer Cell Int; 2022 Apr; 22(1):166. PubMed ID: 35488263
[TBL] [Abstract][Full Text] [Related]
17. Architecture of Cancer-Associated Fibroblasts in Tumor Microenvironment: Mapping Their Origins, Heterogeneity, and Role in Cancer Therapy Resistance.
Dzobo K; Dandara C
OMICS; 2020 Jun; 24(6):314-339. PubMed ID: 32496970
[TBL] [Abstract][Full Text] [Related]
18. The Dark Side of Fibroblasts: Cancer-Associated Fibroblasts as Mediators of Immunosuppression in the Tumor Microenvironment.
Monteran L; Erez N
Front Immunol; 2019; 10():1835. PubMed ID: 31428105
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia-Induced Signaling Promotes Prostate Cancer Progression: Exosomes Role as Messenger of Hypoxic Response in Tumor Microenvironment.
Deep G; Panigrahi GK
Crit Rev Oncog; 2015; 20(5-6):419-34. PubMed ID: 27279239
[TBL] [Abstract][Full Text] [Related]
20. Cancer-associated fibroblasts and the tumor microenvironment in non-small cell lung cancer.
Suzuki J; Tsuboi M; Ishii G
Expert Rev Anticancer Ther; 2022 Feb; 22(2):169-182. PubMed ID: 34904919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
